These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 33560097

  • 21. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC, Ter Heine R, Schouten JA, Hunfeld NG, van Leeuwen HJ, Verweij PE, de Lange DW, Pickkers P, Brüggemann RJ.
    Clin Pharmacokinet; 2017 Oct; 56(10):1197-1206. PubMed ID: 28144840
    [Abstract] [Full Text] [Related]

  • 22. Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
    Ulldemolins M, Martín-Loeches I, Llauradó-Serra M, Fernández J, Vaquer S, Rodríguez A, Pontes C, Calvo G, Torres A, Soy D.
    J Antimicrob Chemother; 2016 Jun; 71(6):1651-9. PubMed ID: 26869692
    [Abstract] [Full Text] [Related]

  • 23. Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study.
    Xu J, Duan L, Li J, Chen F, Xu X, Lu J, Zhuang Z, Cao Y, Yuan Y, Liu X, Sun J, Zhou Q, Shi L, Tang L.
    BMC Infect Dis; 2022 Aug 02; 22(1):667. PubMed ID: 35918657
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW.
    Pharmacotherapy; 2019 Nov 02; 39(11):1066-1076. PubMed ID: 31549737
    [Abstract] [Full Text] [Related]

  • 25. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
    Novy E, Abdul-Aziz MH, Cheng V, Burrows F, Buscher H, Corley A, Diehl A, Gilder E, Levkovich BJ, McGuinness S, Ordonez J, Parke R, Parker S, Pellegrino V, Reynolds C, Rudham S, Wallis SC, Welch SA, Fraser JF, Shekar K, Roberts JA.
    Antimicrob Agents Chemother; 2024 Jan 10; 68(1):e0120123. PubMed ID: 38063399
    [Abstract] [Full Text] [Related]

  • 26. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK, Foudraine NA, Burgers DM, Neef K, le Noble JL.
    Ther Drug Monit; 2016 Dec 10; 38(6):699-705. PubMed ID: 27494946
    [Abstract] [Full Text] [Related]

  • 27. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
    Vossen MG, Knafl D, Haidinger M, Lemmerer R, Unger M, Pferschy S, Lamm W, Maier-Salamon A, Jäger W, Thalhammer F.
    Antimicrob Agents Chemother; 2017 Aug 10; 61(8):. PubMed ID: 28584142
    [Abstract] [Full Text] [Related]

  • 28. Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.
    Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, Boonpeng A, Srisawat N, Pattharachayakul S.
    Blood Purif; 2023 Aug 10; 52(6):503-515. PubMed ID: 37231811
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA, Roberts DM, Udy AA, Mat-Nor MB, Mohamad-Nor FS, Wallis SC, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2015 Jul 10; 46(1):39-44. PubMed ID: 25881872
    [Abstract] [Full Text] [Related]

  • 30. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    He S, Cheng Z, Xie F.
    Drug Des Devel Ther; 2022 Jul 10; 16():13-22. PubMed ID: 35023902
    [Abstract] [Full Text] [Related]

  • 31. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA, Udy AA, Bulitta JB, Stuart J, Jarrett P, Starr T, Lassig-Smith M, Roberts NA, Dunlop R, Hayashi Y, Wallis SC, Lipman J.
    J Antimicrob Chemother; 2014 Sep 10; 69(9):2508-16. PubMed ID: 24879665
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and Pharmacodynamics of Linezolid in Patients With Sepsis Receiving Continuous Venovenous Hemofiltration and Extended Daily Hemofiltration.
    Zheng J, Sun Z, Sun L, Zhang X, Hou G, Han Q, Li X, Liu G, Gao Y, Ye M, Wang H, Yu K.
    J Infect Dis; 2020 Mar 16; 221(Suppl 2):S279-S287. PubMed ID: 32176792
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis With High Cutoff Membranes.
    Tenorio-Cañamás T, Grau S, Luque S, Fortún J, Liaño F, Roberts JA.
    Ther Drug Monit; 2019 Jun 16; 41(3):376-382. PubMed ID: 30633087
    [Abstract] [Full Text] [Related]

  • 34. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V, Abdul-Aziz MH, Burrows F, Buscher H, Corley A, Diehl A, Levkovich BJ, Pellegrino V, Reynolds C, Rudham S, Wallis SC, Welch SA, Roberts JA, Shekar K, Fraser JF, ASAP ECMO Investigators.
    Anaesth Crit Care Pain Med; 2022 Jun 16; 41(3):101080. PubMed ID: 35472580
    [Abstract] [Full Text] [Related]

  • 35. Steady-State Ceftazidime-Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration.
    Soukup P, Faust AC, Edpuganti V, Putnam WC, McKinnell JA.
    Pharmacotherapy; 2019 Dec 16; 39(12):1216-1222. PubMed ID: 31596506
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients.
    Ikawa K, Morikawa N, Suyama H, Ikeda K, Yamanoue T.
    J Infect Chemother; 2009 Dec 16; 15(6):420-3. PubMed ID: 20012736
    [Abstract] [Full Text] [Related]

  • 37. Optimized meropenem dosage regimens using a pharmacokinetic/pharmacodynamic population approach in patients undergoing continuous venovenous haemodiafiltration with high-adsorbent membrane.
    Padullés Zamora A, Juvany Roig R, Leiva Badosa E, Sabater Riera J, Pérez Fernández XL, Cárdenas Campos P, Rigo Bonin R, Alía Ramos P, Tubau Quintano F, Sospedra Martinez E, Colom Codina H.
    J Antimicrob Chemother; 2019 Oct 01; 74(10):2979-2983. PubMed ID: 31335959
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN, Teitelbaum I, Abraham E.
    Antimicrob Agents Chemother; 2005 Jun 01; 49(6):2421-8. PubMed ID: 15917542
    [Abstract] [Full Text] [Related]

  • 39. Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: a retrospective cohort study from a Canadian tertiary centre.
    AlEnezi F, Alhazzani W, Ma J, Alanazi S, Salib M, Attia M, Thabane L, Fox-Robichaud A.
    Can Respir J; 2014 Jun 01; 21(3):176-80. PubMed ID: 24712012
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.
    Horvatits T, Kitzberger R, Drolz A, Zauner C, Jäger W, Böhmdorfer M, Kraff S, Fritsch A, Thalhammer F, Fuhrmann V, Schenk P.
    Antimicrob Agents Chemother; 2014 Jun 01; 58(1):94-101. PubMed ID: 24145543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.